openPR Logo
Press release

Human Growth Hormone Market Outlook Signals Expansion To $7.87 Billion Through 2030

08-20-2026 10:05 AM CET | Health & Medicine

Press release from: The Business Research Company

Human Growth Hormone Market

Human Growth Hormone Market

The human growth hormone market is positioned for significant expansion in the coming years, driven by advancements in medical treatments and shifting patient needs. As therapies become more refined and accessible, the demand for these hormones is expected to rise steadily. This overview explores the market's size, key players, emerging trends, and segmentation to provide a clear understanding of its future trajectory.

Forecasted Market Size and Growth of the Human Growth Hormone Market
The human growth hormone market is projected to reach a value of $7.87 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.5%. Several factors contribute to this anticipated growth, including increasing demand for long-acting growth hormone therapies, a rising number of adults diagnosed with growth hormone deficiency, and a greater emphasis on personalized endocrine treatments. The expansion of specialty pharmacy distribution networks and enhanced investments in hormone therapy research also play crucial roles. Key trends shaping the market during this period include growing preference for growth hormone deficiency treatments, wider adoption of long-acting growth hormone formulations, increased use of human growth hormone (hgh) in pediatric endocrinology, expansion of recombinant growth hormone therapies, and a focus on improving patient adherence through more convenient administration methods.

The human growth hormone market size has grown strongly in recent years. It will grow from $5.18 billion in 2025 to $5.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing diagnosis of growth hormone deficiency, expansion of recombinant hormone production, growing awareness of pediatric growth disorders, rising availability of branded hgh therapies, long-standing clinical use of hormone replacement.

Download a free sample of the human growth hormone market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Fueling Growth in the Human Growth Hormone Market
One major driver behind the market's growth is the rising demand for treatments targeting growth hormone deficiency across different age groups, especially adults and children. This need is spurring innovation in therapy options and encouraging pharmaceutical companies to develop more effective and patient-friendly treatments.

Additionally, the growing focus on personalized medicine within endocrine therapy is pushing advancements. Tailored treatment plans that cater to individual patient profiles are becoming standard, enhancing outcomes and patient satisfaction. This shift is supporting the ongoing market expansion and driving new developments in human growth hormone products.

View the full human growth hormone market report:
https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Influencing the Human Growth Hormone Market Landscape
The competitive landscape of the human growth hormone market features several prominent players, including Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., and Rani Therapeutics. These companies are key contributors to the innovation and commercialization of new growth hormone therapies worldwide.

How Current Trends are Shaping the Human Growth Hormone Market
Pharmaceutical firms are increasingly prioritizing drug development and regulatory approvals to improve treatment offerings and patient experiences. The drug development process involves rigorous testing and evaluation to ensure safety, efficacy, and quality before products reach the market. This dedication to innovation is boosting the availability of advanced therapies.

For example, in June 2023, Pfizer Inc. and OPKO Health Inc., both US-based biopharmaceutical companies, gained FDA approval for NGENLA (somatrogon-ghla), a treatment designed to simplify dosing schedules and improve patient adherence. NGENLA allows children with growth hormone deficiency to reduce injection frequency from daily to once weekly. This approval was backed by a Phase 3 study that demonstrated NGENLA's comparable effectiveness and safety to once-daily somatropin, marking an important step forward in patient-friendly hormone therapies.

Breakdown of Major Segments in the Global Human Growth Hormone Market
The human growth hormone market is segmented by product type, brand, administration route, distribution channel, and application areas. Specifically, the product categories include liquid and powder forms. Within these, liquid products are further divided into pre-filled liquid syringes and vials, while powder forms consist of reconstitutable and freeze-dried powders.

Brand segmentation highlights well-known names such as Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, along with other brands. The market is also categorized by route of administration into intramuscular and subcutaneous. Distribution channels cover hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies.

In terms of applications, the market addresses multiple conditions, including general growth hormone (GH) deficiency, adult GH deficiency, pediatric GH deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, small for gestational age, and other related uses. This comprehensive segmentation reflects the diverse therapeutic needs and delivery methods in this evolving market.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Growth Hormone Market Outlook Signals Expansion To $7.87 Billion Through 2030 here

News-ID: 4608410 • Views:

More Releases from The Business Research Company

Image Guided And Robotic Assisted Procedures Market Analysis Highlights Growth To $11.16 Billion By 2030 At 15.5% CAGR
Image Guided And Robotic Assisted Procedures Market Analysis Highlights Growth T …
The field of image guided and robotic assisted procedures is on the brink of remarkable expansion, driven by technological progress and growing clinical adoption. Innovations in surgical robotics and imaging technologies are opening new avenues for precision surgery, promising enhanced patient outcomes and operational efficiency. Here is an overview of the market's current state, the key players shaping its future, emerging trends, and the market segments that are driving its
ICU Beds Market Study Highlights How Industry Demand Is Evolving
ICU Beds Market Study Highlights How Industry Demand Is Evolving
The ICU beds market is poised for significant expansion as advancements in healthcare infrastructure and technology continue to evolve. Growing investments in critical care facilities and a push toward smarter, more connected medical equipment are driving this sector forward. Let's explore the current market size, key players, notable trends, and essential segments shaping the future of ICU beds. Projected Market Expansion and Forecast for ICU Beds The ICU beds market
Hypertrophic Cardiomyopathy Treatment Market Research Reveals Strong 5.4% CAGR Outlook Through 2030
Hypertrophic Cardiomyopathy Treatment Market Research Reveals Strong 5.4% CAGR O …
The treatment landscape for hypertrophic cardiomyopathy (HCM) is evolving rapidly as advancements in medical technology and personalized care approaches gain traction. With increasing awareness and improved diagnostic methods, the market for HCM treatments is positioned for steady expansion in the coming years. Below is a detailed overview of the current market size, key players, influential trends, and segmentation within this important healthcare sector. Projected Market Size and Growth Trajectory of the
Hyperpigmentation Disorder Treatment Market Intelligence Report Covers Trends, Segments And Regional Growth
Hyperpigmentation Disorder Treatment Market Intelligence Report Covers Trends, S …
The hyperpigmentation disorder treatment market is on track for substantial growth through the end of the decade. With increasing consumer awareness and advancements in skincare technologies, this sector is expected to expand rapidly, driven by innovative treatment options and rising demand across various demographics. Anticipated Expansion of the Hyperpigmentation Disorder Treatment Market by 2030 Forecasts indicate that the hyperpigmentation disorder treatment market will reach a value of $9.36 billion by

All 5 Releases


More Releases for Human

Mooka: Replacing Human Error with AI - Not Human Connection
Salt Lake City, UT - October 21, 2025 - In an era where automation and artificial intelligence are reshaping nearly every corner of online retail, Mooka [https://www.mooka.io/], a leader in eCommerce automation and marketplace optimization, is taking a clear stand: AI should replace human error, not human interaction. As eCommerce continues to scale, many sellers face a growing challenge-how to keep operations efficient while preserving the human touch that builds trust,
Tennessee United for Human Rights Challenging Hate this Human Rights Day
Nashville, Tennessee, 10th October 2025, ZEX PR WIRE, Tennessee United for Human Rights (TNUHR) coordinates with human rights agencies across the state to organize the annual Human Rights Day celebration, set for December 10, 2025, in Nashville, Tennessee. This year's theme, "Challenging Hate: Standing Together for Universal Human Rights," reflects the ongoing commitment of local organizations to unite communities, confront prejudice, and promote equality and understanding for all. The celebration will honor
Global Human Augmentation Market 2024-2031: Advancing Human Potential Through Te …
Global Human Augmentation Market reached US$ 252.6 Billion in 2023 and is expected to reach US$ 780.7 Billion by 2031, growing with a CAGR of 15.6% during the forecast period 2024-2031. The Human Augmentation Market focuses on technologies enhancing human capabilities through wearable exoskeletons, neural interfaces, prosthetics, and performance-enhancing devices. Growth is fueled by medical rehabilitation, industrial automation, defense applications, and lifestyle technology. Advances in robotics, AI, and brain-computer interfaces expand
Human Factors and Usability Engineering Services Market Key Players Analysis - H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Human Factors and Usability Engineering Services Market"-, By Steps Involved (Summative Study, Contextual Analysis, Formative Study, Known Use Error Analysis, Use Risk Analysis, Submission Preparation, Design Process and Task Analysis), By Type of Research Method (Evaluation Research and Generative Research), Class of Medical Device Tested (Class I, Class II and Class III ), Industry Trends, and
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake. If someone
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern